by Laura Smith | Sep 2, 2022 | Communications, Weekly Cannabis News
Weekly Cannabis News August 26th – September 2nd, 2022 Effects of Δ9-Tetrahydrocannabinol (Δ9-THC) & Cannabidiol (CBD) on Salivation Results from animal studies showed that Δ9-THC, but not CBD treatment reduced basal salivation. However, CBD did reverse the...by Laura Smith | Aug 30, 2022 | Communications, Weekly Cannabis News
Weekly Cannabis News August 19th – August 26th, 2022 Low ∆9-Tetrahydrocannabinol (∆9-THC) Cannabis Oil for Fibromyalgia (FM) Treatment Study results showed that this cannabis extract was effective in reversing FM symptoms in a mouse model. Fibromyalgia (FM) is a...by Laura Smith | Aug 19, 2022 | Communications, Weekly Cannabis News
Weekly Cannabis News August 12th – August 19th, 2022 Post-Traumatic Stress Disorder (PTSD) & Cannabis Use During COVID-19 Individuals who reported an increase in cannabis consumption during the pandemic displayed worsening depressive symptoms, a new study...by Laura Smith | Aug 17, 2022 | Market Intelligence
Csequence is proud to announce the first part of our virtual expert panel series on the use of cannabis in fighting cancer. In July we heard from physicians who discussed their views on the topic, the data they have seen and the trials they are working on. This...by Laura Smith | Aug 11, 2022 | Communications, Weekly Cannabis News
Weekly Cannabis News August 5th – August 12th, 2022 Cannabis Use & COVID-19 Symptoms Severity COVID-19 cannabis consumers reported better clinical outcomes compared to non-consumers, suggesting the need for additional investigations. The novel severe acute...